These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26253325)

  • 1. Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.
    Abou Al-Shaar H; Almefty KK; Abolfotoh M; Arvold ND; Devlin PM; Reardon DA; Loeffler JS; Al-Mefty O
    J Neurooncol; 2015 Sep; 124(3):515-22. PubMed ID: 26253325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
    Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
    Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
    J Neurosurg; 2019 Dec; 131(6):1819-1828. PubMed ID: 30579269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
    Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
    Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.
    Koch MJ; Agarwalla PK; Royce TJ; Shih HA; Oh K; Niemierko A; Mauceri TC; Curry WT; Barker FG; Loeffler JS
    Neurosurgery; 2019 Nov; 85(5):E910-E916. PubMed ID: 31329941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection.
    Mooney MA; Abolfotoh M; Bi WL; Tavanaiepour D; Almefty RO; Bassiouni H; Pravdenkova S; Dunn IF; Al-Mefty O
    Neurosurgery; 2020 Oct; 87(5):900-909. PubMed ID: 32294205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
    Mooney MA; Bi WL; Cantalino JM; Wu KC; Harris TC; Possatti LL; Juvekar P; Hsu L; Dunn IF; Al-Mefty O; Devlin PM
    J Neurooncol; 2020 Jan; 146(1):111-120. PubMed ID: 31745706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Atypical and Anaplastic Meningiomas.
    Buttrick S; Shah AH; Komotar RJ; Ivan ME
    Neurosurg Clin N Am; 2016 Apr; 27(2):239-47. PubMed ID: 27012388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of brachytherapy in the management of the skull base meningioma. Treatment of skull base meningiomas.
    Kumar PP; Patil AA; Syh HW; Chu WK; Reeves MA
    Cancer; 1993 Jun; 71(11):3726-31. PubMed ID: 8490923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachytherapy: a viable alternative in the management of basal meningiomas.
    Kumar PP; Patil AA; Leibrock LG; Chu WK; Syh J; McCaul GF; Reeves MA
    Neurosurgery; 1991 Nov; 29(5):676-80. PubMed ID: 1961396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical treatment strategies improve the long-term outcome of recurrent atypical meningiomas.
    Li F; Lai ZP; Lin JK; Zhu G; Feng H
    Chin Med J (Engl); 2011 Aug; 124(15):2387-91. PubMed ID: 22029080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalation with proton radiation therapy for high-grade meningiomas.
    Chan AW; Bernstein KD; Adams JA; Parambi RJ; Loeffler JS
    Technol Cancer Res Treat; 2012 Dec; 11(6):607-14. PubMed ID: 22712601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachytherapy for intracranial meningioma using a permanently implanted iodine-125 seed.
    Obasi PC; Barnett GH; Suh JH
    Stereotact Funct Neurosurg; 2002; 79(1):33-43. PubMed ID: 12677103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
    Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
    J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachytherapy for meningiomas.
    Magill ST; Schwartz TH; Theodosopoulos PV; McDermott MW
    Handb Clin Neurol; 2020; 170():303-307. PubMed ID: 32586503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.
    Sajja R; Barnett GH; Lee SY; Harnisch G; Stevens GH; Lee J; Suh JH
    Technol Cancer Res Treat; 2005 Dec; 4(6):675-82. PubMed ID: 16292888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources.
    Gutin PH; Leibel SA; Hosobuchi Y; Crumley RL; Edwards MS; Wilson CB; Lamb S; Weaver KA
    Neurosurgery; 1987 Jun; 20(6):938-45. PubMed ID: 3614575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method for treatment of unresectable, recurrent brain tumors with single permanent high-activity 125iodine brachytherapy.
    Kumar PP; Good RR; Jones EO; Hahn FJ; McCaul GF; Gallagher TF; Cox TA; Leibrock LG; Skultety MF
    Radiat Med; 1986; 4(1):12-20. PubMed ID: 3775067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study.
    Momin AA; Shao J; Soni P; Almeida JP; Suh JH; Murphy ES; Chao ST; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
    J Neurooncol; 2021 Apr; 152(2):373-382. PubMed ID: 33590402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.